To arm Family Physicians with the latest resources for combating the opioid abuse and overdose crisis, AAFP recently released a new chronic pain management toolkit and a free members-only CME webcast focused on chronic opioid therapy.
The comprehensive, dynamic toolkit includes an action plan, pain inventory, work questionnaire, patient-physician medication agreement, and opioid risk tool. It also links to additional AAFP and external resources for physicians. Everything included in the toolkit is consistent with key recommendations in the CDC and Federation of State Medical Boards guidelines.
The hour-long, members-only webcast—recorded on May 27 and worth one AAFP Prescribed credit—is taught by David Walsworth, MD, Associate Chair for Clinical Affairs and Associate Professor in the Department of Family Medicine at the Michigan State University College of Human Medicine.
The CME course teaches Family Physicians how to evaluate patients presenting with chronic nonterminal pain to assess for potential opioid responsiveness and opioid risk, and how to best develop an evidence-based treatment plan. It also covers how to use state prescription monitoring programs, patient-prescriber agreements, patient counseling documents and documented urine drug screening.
Learn More from Dr. Walsworth In-Person
You have the opportunity to learn more from Dr. Walsworth by attending the Michigan Family Medicine Annual Conference live CME session, "The Many Facets of Chronic Pain Management," on July 12 at 10:15-11:15 a.m. in Bay City. He will discuss how to choose the appropriate pharmacological and/or non-pharmacological therapy based on patient characteristics; engage patients in conversation about their pain; and use shared decision-making to develop individualized pain management plans based on current evidence and guidelines. REGISTER FOR THE CONFERENCE
American Board of Medicine Adopts New Opioid Policies
One June 15, during the American Medical Association's Annual Meeting, physician delegates approved several resolutions for addressing the opioid use and overdose epidemic, including policies to promote the importance and effectiveness of prescription drug monitoring programs, increase access to naloxone, break down barriers to pain management. READ MORE